← All trials
NCT06437080
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2022
- Primary completion
- Oct 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- May 31, 2024
- Last posted
- Jun 4, 2024
- Enrollment
- 1331
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Akram Medical ComplexLead sponsor
- Akram Medical ComplexSponsor investigator
- Scotmann PharmaceuticalsCollaborator
- University of Health Sciences LahoreCollaborator
- G D SearleCollaborator
- University of the PunjabOfficial
- University of Health Sciences LahoreSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.